Xiaoling Li
- Cancer Research top 0.5%
- Cancer-related molecular mechanisms research 12
- Immunology top 2%
- Molecular Biology top 2%
- Chromatin Remodeling and Cancer 17
- RNA modifications and cancer 16
- Cancer-related gene regulation 14
- Genomics and Chromatin Dynamics 10
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 11
-
- Lung Cancer Treatments and Mutations 15
- Ferroptosis and cancer prognosis 13
- Journals
- Journal of Biological Chemistry (6 papers)Molecular Cancer (6 papers)Cancer Letters (4 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Xiaoling Li
214 papers receiving 6.8k citations
Hit Papers
Peers
Comparison fields: 5 of 161
- Cancer Research 1.8k
- Immunology 1.3k
- Molecular Biology 3.6k
- Oncology 1.4k
- Pulmonary and Respiratory Medicine 1.1k
Countries citing papers authored by Xiaoling Li
This map shows the geographic impact of Xiaoling Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoling Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoling Li more than expected).
Fields of papers citing papers by Xiaoling Li
This network shows the impact of papers produced by Xiaoling Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoling Li. The network helps show where Xiaoling Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Xiaoling Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 3 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 2 | |
| 6 | 2025 | 3 | |
| 7 | 2025 | 0 | |
| 8 | 2024 | 1 | |
| 9 | 2024 | 2 | |
| 10 | 2024 | 7 | |
| 11 | 2024 | 3 | |
| 12 | 2023 | 4 | |
| 13 | 2023 | 44 | |
| 14 | 2023 | 4 | |
| 15 | 2022 | 2 | |
| 16 | 2021 | 53 | |
| 17 | In Vitro Cytotoxicity and In Vivo Anti-Tumor Efficacy of CD13 Targeted Peptide-Monomethyl Auristatin E (MMAE) Conjugates | 2019 | 3 |
| 18 | 2018 | 36 | |
| 19 | Characterization analysis of nasopharyngeal carcinoma differentially expressed gene PROL4 | 2003 | 1 |
| 20 | Cloning of eukaryotic gene and expression | 2002 | 1 |
About Xiaoling Li
Xiaoling Li is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Immunology, having authored 224 papers that have together received 6.9k indexed citations. Recurring topics across this work include Chromatin Remodeling and Cancer (17 papers), RNA modifications and cancer (16 papers), Lung Cancer Treatments and Mutations (15 papers), Cancer-related gene regulation (14 papers), Ferroptosis and cancer prognosis (13 papers), Cancer-related molecular mechanisms research (12 papers), Cancer Immunotherapy and Biomarkers (11 papers) and Genomics and Chromatin Dynamics (10 papers). The work is most often cited by research in Cancer Research (1.8k citations), Immunology (1.3k citations), Molecular Biology (3.6k citations), Oncology (1.4k citations) and Pulmonary and Respiratory Medicine (1.1k citations). Xiaoling Li has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Can Guo, Bo Xiang, Yong Li, Ming Zhou, Yongzhen Mo, Fang Xiong and Lianxiang Luo. Their work appears in journals such as Journal of Biological Chemistry, Molecular Cancer, Cancer Letters, Journal of Experimental & Clinical Cancer Research and Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.